Eagle Global Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.74M | Buy |
53,536
+160
| +0.3% | +$11.2K | 0.15% | 103 |
|
|
2025
Q1 | $3.92M | Sell |
53,376
-2,530
| -5% | -$186K | 0.16% | 99 |
|
|
2024
Q4 | $3.66M | Sell |
55,906
-3,350
| -6% | -$219K | 0.15% | 100 |
|
|
2024
Q3 | $4.62M | Sell |
59,256
-580
| -1% | -$45.2K | 0.23% | 79 |
|
|
2024
Q2 | $4.67M | Buy |
59,836
+3,425
| +6% | +$267K | 0.25% | 77 |
|
|
2024
Q1 | $3.82M | Buy |
56,411
+16,026
| +40% | +$1.09M | 0.22% | 81 |
|
|
2023
Q4 | $2.72M | Sell |
40,385
-1,115
| -3% | -$75.1K | 0.16% | 99 |
|
|
2023
Q3 | $2.81M | Buy |
41,500
+15,425
| +59% | +$1.04M | 0.18% | 97 |
|
|
2023
Q2 | $1.87M | Buy |
26,075
+1,480
| +6% | +$106K | 0.12% | 118 |
|
|
2023
Q1 | $1.71M | Buy |
+24,595
| New | +$1.71M | 0.12% | 120 |
|